subscribeSubscribe
US FDA sends warning letter to Cardinal Health for marketing unapproved devices

US FDA sends warning letter to Cardinal Health for marketing unapproved devices
REUTERS
25 Apr 2024
Share Share
Zydus Lifesciences gets 10 observations from USFDA for Jarod injectable facility

Zydus Lifesciences gets 10 observations from USFDA for Jarod injectable facility
INDINPHARMAPOST
24 Apr 2024
Share Share
Jubilant Pharmova announces completion of USFDA audit of Radiopharmaceuticals

Jubilant Pharmova announces completion of USFDA audit of Radiopharmaceuticals
INDINPHARMAPOST
24 Apr 2024
Share Share
Dr Reddy`s recalls six lots of drug in US due to subpotency

Dr Reddy`s recalls six lots of drug in US due to subpotency
ECONOMICTIMES
23 Apr 2024
Share Share
Aarti Drugs receives five observations in Form 483 from USFDA Himachal facility

Aarti Drugs receives five observations in Form 483 from USFDA Himachal facility
UPSTOX
23 Apr 2024
Share Share
Biosplice searches for a path forward osteoarthritis drug fails late-stage study

Biosplice searches for a path forward osteoarthritis drug fails late-stage study
Jared Whitlock ENDPTS
22 Apr 2024
Share Share
Par Pharma recalls blood pressure med for possible contamination

Par Pharma recalls blood pressure med for possible contamination
Joseph Keenan FIERCE PHARMA
22 Apr 2024
Share Share
USFDA pulls up Natco Pharma for several violations at Telangana plant

USFDA pulls up Natco Pharma for several violations at Telangana plant
BUSINESS STANDARD
22 Apr 2024
Share Share
Marksans declines after US FDA issues Form 483 with 5 observations to Goan plant

Marksans declines after US FDA issues Form 483 with 5 observations to Goan plant
BUSINESS STANDARD
18 Apr 2024
Share Share
FDA classifies recall of Boston Scientific device as `most serious`

FDA classifies recall of Boston Scientific device as `most serious`
REUTERS
18 Apr 2024
Share Share